Metabolic Bone Disease in Adults with Inflammatory Bowel Disease

Overview

Journal Inflamm Bowel Dis

Publisher Oxford University Press

Specialty Gastroenterology

Date 1999 Aug 24

PMID 10453377

Citations 4

Authors

J D Adachi

A Rostom

Affiliations

Soon will be listed here.

Abstract

Bone loss is seen frequently in those with inflammatory bowel disease (IBD). It appears to be more common in those with Crohn's disease than in those with ulcerative colitis. Corticosteroids play an important role in the development of osteoporosis. The prevalence of osteoporosis in IBD, the effects of corticosteroids on bone metabolism, and treatment options are reviewed.

Citing Articles

Enteral nutrition in Crohn's disease: an underused therapy.

Kansal S, Wagner J, Kirkwood C, Catto-Smith A Gastroenterol Res Pract. 2014; 2013:482108.

PMID: 24382954 PMC: 3870077. DOI: 10.1155/2013/482108.

Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Abreu M, Kantorovich V, Vasiliauskas E, Gruntmanis U, Matuk R, Daigle K Gut. 2004; 53(8):1129-36.

PMID: 15247180 PMC: 1774134. DOI: 10.1136/gut.2003.036657.

Metabolic bone disease in IBD.

Lopez I, Buchman A Curr Gastroenterol Rep. 2000; 2(4):317-22.

PMID: 10981030 DOI: 10.1007/s11894-000-0025-9.

Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.

Cranney A, Welch V, Adachi J, Homik J, Shea B, Suarez-Almazor M Cochrane Database Syst Rev. 2000; (2):CD001983.

PMID: 10796457 PMC: 8409281. DOI: 10.1002/14651858.CD001983.